Nitric Oxide Therapy
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
322
NCT01768884
Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With Bronchiolitis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2013
Completion: Jan 31, 2016
NCT01958944
Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis
Start: Dec 31, 2013
Completion: Nov 30, 2015
NCT03053388
Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Phase: Phase 3
Start: Mar 5, 2017
Completion: Apr 28, 2018
NCT03208764
Inhaled Nitric Oxide for Patients With MABSC
Phase: Phase 2
Start: Jul 24, 2017
Completion: Apr 11, 2019
NCT04060979
Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Start: Nov 6, 2019
Completion: Apr 2, 2020
NCT04397692
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
Phase: N/A
Start: Jun 13, 2020
Completion: Sep 30, 2020
NCT04456088
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)
Start: Jul 15, 2020
Completion: Dec 15, 2020
NCT04606407
Inhaled NO for the Treatment of Viral Pneumonia in Adults
Start: Nov 25, 2020
Completion: Aug 7, 2022
NCT04685720
A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients
Start: Dec 7, 2020
Completion: Oct 10, 2022
NCT05351502
A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors
Phase: Phase 1
Start: Aug 14, 2022
Completion: Jun 30, 2025
Loading map...